Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DR REDDYS LABORATORIES LTD Board/Management Information 2024

Mar 22, 2024

30528_rns_2024-03-22_28b2bdc0-49dc-4018-9a15-a57d7866d595.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [452 x 114] intentionally omitted <==

March 22, 2024

National Stock Exchange of India Ltd. (Stock Code: DRREDDY-EQ) BSE Limited (Stock Code: 500124)

New York Stock Exchange Inc. (Stock Code: RDY) NSE IFSC Ltd. (Stock Code: DRREDDY)

Sub: Intimation regarding Board Meeting and Trading Window Closure

Dear Sir/Madam,

Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby intimate you that a meeting of the Board of Directors of the Company will be held on Tuesday, May 7, 2024, inter alia , to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ending on March 31, 2024, and to recommend dividend, if any, for the financial year 2023-24.

Further, kindly note that, under the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons, the trading window for dealing in securities of the Company will be closed from March 25, 2024, to May 9, 2024 (both days inclusive).

This is for your information and records.

Thanking you.

Yours faithfully,

For Dr. Reddy’s Laboratories Limited

KUMAR Digitally signed by KUMAR RANDHIR RANDHIR SINGH Date: 2024.03.22 SINGH 15:41:57 +05'30'

K Randhir Singh

Company Secretary, Compliance Officer and Head CSR